BGM is a 100% black owned, BBBEE Level 1 pharmaceutical company founded in 2013 by Dr. Blaine and Mr. Mark Bloy. The company was built with the vision of providing safe, quality, cost-effective, innovate medicines to South African patients.
Our portfolio of products and healthcare technologies are carefully selected to meet the health-related needs of Healthcare Practitioners and Patients on the African continent.
BGM is Proudly a B BBEE Level 1 Company
Our Ethics are based on the below qualities:
Innovation often results when ideas are applied by the company in order to further satisfy the needs and expectations of the customers.
Innovation is crucial to the continuing success of any organization.
At BGM Pharmaceuticals we strive to have a meaningful impact on lives of Africans through Quality Health Innovations.
We continue to try and forge an internal culture that bolters 6 important values of innovation as we grow & develop to serve our clients & customers better:
BGM Pharmaceuticals has combined expertise of over 125 years in the field of Pharmacology, Medical, Regulatory and Business.
Within our internal culture we stress the importance of knowledge & education as we are a growing business committed to serving our clientbase with innovative solutions and this in turn helps our customers experience of the way we do business.
We foster a culture of the six pillars of customer experience:
BGM Pharmaceuticals has focused all their efforts on building a pipeline of Biosimilars which will be developed using plant-based technology.
We are building a Dream Team that already holds collectivity 125+ years of Pharmacology, Medical, Regulatory and Business experience.
BGM is building a portfolio through the acquisition of dossiers which are then submitted to SAHPRA for registration with BGM as the license holder.
Global and Local Sourcing is a Procurement Strategy we use as this holds efficiencies for the delivery of our goods and services to local & international markets.